Dr. Natalie Ivana Bene, MD

Dr. Bene practices at Pennsylvania Dermatology Partners Inc in Birdsboro, Pennsylvania.

Dr. Bene's NPI, 1164405353, was assigned on November 22, 2005. Dr. Bene graduated from Boston University School Of Medicine in 2000. Dr. Bene holds Pennsylvania license MD423402.

Dr. Bene's primary practice is Pennsylvania Dermatology Partners Inc, at 258 Ben Franklin E Hwy, Birdsboro, PA 19508 in Berks County. The practice phone is (610) 288-2908.

Dr. Bene's primary practice is Pennsylvania Dermatology Partners Inc in Birdsboro, Pennsylvania. The medical group on file is Dermatology Partners. Dmand AI also links Dr. Bene to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bene practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Bene's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Bene is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Bene's licenses on file in 4 states: Pennsylvania, Ohio, Maryland and New York.

Dmand AI lists benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, rash and skin cyst among the conditions Dr. Bene treats.

CMS data shows 1,204 Medicare services from Dr. Bene across 16 procedure codes in 2024, for 304 Medicare patients. Medicare paid $151,240 for them. Every service was in an office.

CMS counts 304 Medicare patients who saw Dr. Bene in 2024. The largest group is 65 to 74, with 154 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bene's median patient age at 68, with 56% women.

In 2024, Dr. Bene wrote 260 Medicare Part D claims for 132 patients. 100% of them were for generic drugs. CMS names the drug for 214 of them, across 4 drugs with 11 or more claims each, at $2,673 in total drug cost. In 2023, CMS named 125 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 71 out of 100 for Dr. Bene for performance year 2024, reported as part of a group. Dr. Bene accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 956 procedures of removal of skin lesions by Dr. Bene, more than 93% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Bene, published from 2007 to 2008. The most frequent topics are Facial Neoplasms and Skin Neoplasms. Dr. Bene has published most often in Dermatol Surg. Dr. Bene's most frequent co-authors are Brett M. Coldiron, MD, Karen L. Beasley, MD and Robert George Weiss, MD.

CMS Open Payments shows 319 general payments to Dr. Bene from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Galderma Laboratories, L.P. paid the most, $1,012.

Dmand AI lists 2 awards for Dr. Bene, most recently CMS Stage 1 2012 in 2012.

Dr. Bene graduated from Boston University School Of Medicine in 2000. Dr. Bene is a member of AAD and ASDS.

Dr. Bene is in network with 16 carriers, including Aetna, HCSC and Highmark. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.